Anti-Human NOTCH2 Therapeutic Antibody (Tarextumab)
Recombinant human antibody to Human NOTCH2. Tarextumab (anti-Notch2/3, OMP-59R5) is a novel anti-cancer stem cell antibody identified by screening against the Notch3 receptor that binds to and prevents signaling through both the Notch2 and Notch3 receptors. Tarextumab has been shown in preclinical models to have broad-spectrum anti-tumor activity via inhibition of cancer stem cell growth, and promoting cell differentiation, as well as disrupting tumor angiogenesis by inhibiting vascular pericytes.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-H67 |
| Pricing | Inquiry |
| Host | human |
| Target | NOTCH2 |
| Species Reactivity | Human |
| Type | IgG2 - kappa |
| Applications | FuncS, Block, ELISA |